Geulah Livshits
Stock Analyst at Chardan Capital
(2.07)
# 2,645
Out of 4,670 analysts
163
Total ratings
29.75%
Success rate
-1.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMRX Immuneering | Maintains: Buy | $13 | $2.10 | +519.05% | 8 | Nov 20, 2024 | |
| MGX Metagenomi | Maintains: Buy | $15 | $1.89 | +693.65% | 5 | Nov 20, 2024 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $62 | $14.11 | +339.40% | 14 | Nov 18, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $88 → $91 | $14.30 | +536.36% | 12 | Nov 18, 2024 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $7 | $2.47 | +183.40% | 11 | Nov 14, 2024 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $39 | $7.79 | +400.64% | 6 | Nov 14, 2024 | |
| PRME Prime Medicine | Maintains: Buy | $17 → $15 | $3.20 | +368.75% | 2 | Nov 13, 2024 | |
| LXEO Lexeo Therapeutics | Maintains: Buy | $23 → $25 | $6.47 | +286.40% | 6 | Nov 13, 2024 | |
| CRGX CARGO Therapeutics | Maintains: Buy | $28 | $16.23 | +72.52% | 2 | Nov 13, 2024 | |
| SLDB Solid Biosciences | Maintains: Buy | $15 | $5.41 | +177.26% | 4 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $11 | $1.21 | +809.09% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $2.38 | +656.30% | 8 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 | $2.44 | +391.80% | 9 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $112 → $94 | $47.88 | +96.32% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $208 | $190.40 | +9.24% | 6 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $1.06 | +466.04% | 5 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $8.55 | +297.66% | 10 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $2.17 | +2,664.21% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $5.93 | +591.40% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $0.51 | +1,682.18% | 2 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $7.59 | +229.38% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.87 | +541.71% | 4 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $191 → $208 | $41.11 | +405.96% | 7 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $2.09 | +665.55% | 4 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $2.5 | $7.10 | -64.79% | 5 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $9.59 | +838.48% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $4 | $5.66 | -29.27% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $0.25 | +11,804.76% | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $30 | $6.04 | +396.69% | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $9.82 | +83.30% | 1 | Oct 27, 2020 |
Immuneering
Nov 20, 2024
Maintains: Buy
Price Target: $13
Current: $2.10
Upside: +519.05%
Metagenomi
Nov 20, 2024
Maintains: Buy
Price Target: $15
Current: $1.89
Upside: +693.65%
Rocket Pharmaceuticals
Nov 18, 2024
Maintains: Buy
Price Target: $62
Current: $14.11
Upside: +339.40%
Intellia Therapeutics
Nov 18, 2024
Maintains: Buy
Price Target: $88 → $91
Current: $14.30
Upside: +536.36%
Taysha Gene Therapies
Nov 14, 2024
Maintains: Buy
Price Target: $7
Current: $2.47
Upside: +183.40%
4D Molecular Therapeutics
Nov 14, 2024
Maintains: Buy
Price Target: $39
Current: $7.79
Upside: +400.64%
Prime Medicine
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $3.20
Upside: +368.75%
Lexeo Therapeutics
Nov 13, 2024
Maintains: Buy
Price Target: $23 → $25
Current: $6.47
Upside: +286.40%
CARGO Therapeutics
Nov 13, 2024
Maintains: Buy
Price Target: $28
Current: $16.23
Upside: +72.52%
Solid Biosciences
Nov 11, 2024
Maintains: Buy
Price Target: $15
Current: $5.41
Upside: +177.26%
Nov 7, 2024
Maintains: Buy
Price Target: $17 → $11
Current: $1.21
Upside: +809.09%
Nov 7, 2024
Maintains: Buy
Price Target: $20 → $18
Current: $2.38
Upside: +656.30%
Nov 5, 2024
Maintains: Buy
Price Target: $12
Current: $2.44
Upside: +391.80%
Aug 6, 2024
Maintains: Buy
Price Target: $112 → $94
Current: $47.88
Upside: +96.32%
Aug 5, 2024
Maintains: Buy
Price Target: $153 → $208
Current: $190.40
Upside: +9.24%
Apr 5, 2024
Maintains: Buy
Price Target: $11 → $6
Current: $1.06
Upside: +466.04%
Feb 20, 2024
Maintains: Buy
Price Target: $29 → $34
Current: $8.55
Upside: +297.66%
Aug 15, 2023
Reiterates: Buy
Price Target: $60
Current: $2.17
Upside: +2,664.21%
Aug 11, 2023
Reiterates: Buy
Price Target: $41
Current: $5.93
Upside: +591.40%
Aug 8, 2023
Maintains: Buy
Price Target: $11 → $9
Current: $0.51
Upside: +1,682.18%
Mar 23, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $7.59
Upside: +229.38%
Mar 22, 2023
Reiterates: Buy
Price Target: $12
Current: $1.87
Upside: +541.71%
Jan 18, 2023
Maintains: Neutral
Price Target: $191 → $208
Current: $41.11
Upside: +405.96%
Nov 15, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $2.09
Upside: +665.55%
Aug 22, 2022
Maintains: Buy
Price Target: $4 → $2.5
Current: $7.10
Upside: -64.79%
Nov 3, 2021
Maintains: Buy
Price Target: $100 → $90
Current: $9.59
Upside: +838.48%
Nov 3, 2021
Maintains: Neutral
Price Target: $5.5 → $4
Current: $5.66
Upside: -29.27%
Aug 13, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $0.25
Upside: +11,804.76%
Jul 23, 2021
Maintains: Neutral
Price Target: $50 → $30
Current: $6.04
Upside: +396.69%
Oct 27, 2020
Initiates: Buy
Price Target: $18
Current: $9.82
Upside: +83.30%